The Maryland Stem Cell Research Fund (MSCRF) is focused on identifying and fostering cutting-edge research and innovation in the field of regenerative medicine in Maryland. Our Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland. Since 2007, MSCRF has invested close to $200 million in accelerating stem cell research, cures and commercialization, in addition to building a collaborative stem cell community in our region. Discover how the Maryland Stem Cell Research Fund Accelerates Cures here.

Below is a list of our most current awardees.





Dr. Srinivasa Rao Sripathi

High-Throughput Screen For Small Molecules That Inhibit RPE-EMT as an Approach for Treatment of  AMD

Dr. Patrick Cahan

Distilling Predictive Models of Human Stem Cell Fate Control from Single Cell Omics Data


Post-Doctoral Fellowship
Dr. Bo Am Seo

Mentor: Dr. Hanseok Ko

Neurotoxic Astrocyte Secreted-ExoDrp1 Causes Excessive Mitochondrial Fragmentation and Neurodegeneration of Human Dopaminergic Neurons


Annual Reports

Annual reports include profiles and details on past MSCRF awardees, the MSCR Commission, and closed grant awardees.